Canada markets closed

RedHill Biopharma Ltd. (RDHL)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4280+0.0093 (+2.22%)
At close: 04:00PM EDT
0.4290 +0.00 (+0.23%)
After hours: 07:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 13.64M
Enterprise Value 9.24M
Trailing P/E 0.11
Forward P/E 1.43k
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.42
Price/Book (mrq)6.59
Enterprise Value/Revenue 1.42
Enterprise Value/EBITDA 0.35

Trading Information

Stock Price History

Beta (5Y Monthly) 3.46
52-Week Change 3-80.85%
S&P500 52-Week Change 322.36%
52 Week High 33.2800
52 Week Low 30.2570
50-Day Moving Average 30.5060
200-Day Moving Average 30.8056

Share Statistics

Avg Vol (3 month) 3619.23k
Avg Vol (10 day) 3382.83k
Shares Outstanding 531.87M
Implied Shares Outstanding 611.07M
Float 87.42B
% Held by Insiders 10.00%
% Held by Institutions 16.25%
Shares Short (Apr 15, 2024) 4741.45k
Short Ratio (Apr 15, 2024) 41.79
Short % of Float (Apr 15, 2024) 42.61%
Short % of Shares Outstanding (Apr 15, 2024) 42.33%
Shares Short (prior month Mar 15, 2024) 41.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Mar 23, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 366.25%
Operating Margin (ttm)-1,060.79%

Management Effectiveness

Return on Assets (ttm)-15.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)6.53M
Revenue Per Share (ttm)1.01
Quarterly Revenue Growth (yoy)-95.60%
Gross Profit (ttm)N/A
EBITDA -22.15M
Net Income Avi to Common (ttm)23.92M
Diluted EPS (ttm)4.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.57M
Total Cash Per Share (mrq)0
Total Debt (mrq)1.17M
Total Debt/Equity (mrq)56.69%
Current Ratio (mrq)0.84
Book Value Per Share (mrq)0.10

Cash Flow Statement

Operating Cash Flow (ttm)-35.82M
Levered Free Cash Flow (ttm)-18.23M